Cyclosporine-induced remission of relapsing nephrotic syndrome in children

Amir Tejani, K. halid Butt, H. oward Trachtman, Manikkam Suthanthiran, C. J. Rosenthal, M. R. Khawar

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

We treated 20 steroid-resistant or steroid-dependent nephrotic patients with oral cyclosporine for 8 weeks; they had been treated previously with cyclophosphamide or chlorambucil. Cyclosporine was started at 7 mg/kg/d and titrated to maintain a serum level of 100 to 200 ng/mL. Of 20 patients, 14 had a complete remission and the remaining six had a reduction in their proteinuria. By life table analysis, 40% of the responders show a sustained remission of up to a year. Pretherapy levels of interleukin 2, measured in 10 patients, were normal or supranormal in eight, six of whom were treatment responders; two patients with low levels of interleukin 2 were both nonresponders. Cyclosporine can be used to induce a remission in relapsing nephrotic patients, and short-term cyclosporine therapy does not produce nephrotoxic effects.

Original languageEnglish
Pages (from-to)1056-1062
Number of pages7
JournalThe Journal of Pediatrics
Volume111
Issue number6 PART 2
DOIs
Publication statusPublished - 1 Jan 1987
Externally publishedYes

Fingerprint

Nephrotic Syndrome
Cyclosporine
Interleukin-2
Steroids
Chlorambucil
Life Tables
Proteinuria
Cyclophosphamide
Therapeutics
Serum

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Tejani, A., Butt, K. H., Trachtman, H. O., Suthanthiran, M., Rosenthal, C. J., & Khawar, M. R. (1987). Cyclosporine-induced remission of relapsing nephrotic syndrome in children. The Journal of Pediatrics, 111(6 PART 2), 1056-1062. https://doi.org/10.1016/S0022-3476(87)80056-2

Cyclosporine-induced remission of relapsing nephrotic syndrome in children. / Tejani, Amir; Butt, K. halid; Trachtman, H. oward; Suthanthiran, Manikkam; Rosenthal, C. J.; Khawar, M. R.

In: The Journal of Pediatrics, Vol. 111, No. 6 PART 2, 01.01.1987, p. 1056-1062.

Research output: Contribution to journalArticle

Tejani, A, Butt, KH, Trachtman, HO, Suthanthiran, M, Rosenthal, CJ & Khawar, MR 1987, 'Cyclosporine-induced remission of relapsing nephrotic syndrome in children', The Journal of Pediatrics, vol. 111, no. 6 PART 2, pp. 1056-1062. https://doi.org/10.1016/S0022-3476(87)80056-2
Tejani, Amir ; Butt, K. halid ; Trachtman, H. oward ; Suthanthiran, Manikkam ; Rosenthal, C. J. ; Khawar, M. R. / Cyclosporine-induced remission of relapsing nephrotic syndrome in children. In: The Journal of Pediatrics. 1987 ; Vol. 111, No. 6 PART 2. pp. 1056-1062.
@article{d7897c861c4b4da69919db77cbad4ff0,
title = "Cyclosporine-induced remission of relapsing nephrotic syndrome in children",
abstract = "We treated 20 steroid-resistant or steroid-dependent nephrotic patients with oral cyclosporine for 8 weeks; they had been treated previously with cyclophosphamide or chlorambucil. Cyclosporine was started at 7 mg/kg/d and titrated to maintain a serum level of 100 to 200 ng/mL. Of 20 patients, 14 had a complete remission and the remaining six had a reduction in their proteinuria. By life table analysis, 40{\%} of the responders show a sustained remission of up to a year. Pretherapy levels of interleukin 2, measured in 10 patients, were normal or supranormal in eight, six of whom were treatment responders; two patients with low levels of interleukin 2 were both nonresponders. Cyclosporine can be used to induce a remission in relapsing nephrotic patients, and short-term cyclosporine therapy does not produce nephrotoxic effects.",
author = "Amir Tejani and Butt, {K. halid} and Trachtman, {H. oward} and Manikkam Suthanthiran and Rosenthal, {C. J.} and Khawar, {M. R.}",
year = "1987",
month = "1",
day = "1",
doi = "10.1016/S0022-3476(87)80056-2",
language = "English",
volume = "111",
pages = "1056--1062",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "6 PART 2",

}

TY - JOUR

T1 - Cyclosporine-induced remission of relapsing nephrotic syndrome in children

AU - Tejani, Amir

AU - Butt, K. halid

AU - Trachtman, H. oward

AU - Suthanthiran, Manikkam

AU - Rosenthal, C. J.

AU - Khawar, M. R.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - We treated 20 steroid-resistant or steroid-dependent nephrotic patients with oral cyclosporine for 8 weeks; they had been treated previously with cyclophosphamide or chlorambucil. Cyclosporine was started at 7 mg/kg/d and titrated to maintain a serum level of 100 to 200 ng/mL. Of 20 patients, 14 had a complete remission and the remaining six had a reduction in their proteinuria. By life table analysis, 40% of the responders show a sustained remission of up to a year. Pretherapy levels of interleukin 2, measured in 10 patients, were normal or supranormal in eight, six of whom were treatment responders; two patients with low levels of interleukin 2 were both nonresponders. Cyclosporine can be used to induce a remission in relapsing nephrotic patients, and short-term cyclosporine therapy does not produce nephrotoxic effects.

AB - We treated 20 steroid-resistant or steroid-dependent nephrotic patients with oral cyclosporine for 8 weeks; they had been treated previously with cyclophosphamide or chlorambucil. Cyclosporine was started at 7 mg/kg/d and titrated to maintain a serum level of 100 to 200 ng/mL. Of 20 patients, 14 had a complete remission and the remaining six had a reduction in their proteinuria. By life table analysis, 40% of the responders show a sustained remission of up to a year. Pretherapy levels of interleukin 2, measured in 10 patients, were normal or supranormal in eight, six of whom were treatment responders; two patients with low levels of interleukin 2 were both nonresponders. Cyclosporine can be used to induce a remission in relapsing nephrotic patients, and short-term cyclosporine therapy does not produce nephrotoxic effects.

UR - http://www.scopus.com/inward/record.url?scp=0023575954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023575954&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(87)80056-2

DO - 10.1016/S0022-3476(87)80056-2

M3 - Article

VL - 111

SP - 1056

EP - 1062

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 6 PART 2

ER -